Micro Emerging Active

MRK WINREVAIR Phase 2 CADENCE trial success

Score
0.4
Velocity
▲ 0.0
Articles
2
Sources
2

Summary

An article belongs to this narrative if it discusses Merck's WINREVAIR Phase 2 CADENCE trial results in pulmonary hypertension.

Related Articles

Merck & Co. (MRK) Announces Detailed Results From the Phase 2 CADENCE Study

Yahoo Finance · Apr 02, 2026
Mixed

Merck's WINREVAIR Phase 2 CADENCE Trial Shows Positive Proof-of-Concept In Pulmonary Hypertension

Nasdaq · Mar 29, 2026
Mixed

Sources

Merck & Co. (MRK) Announces Detailed Results From the Phase … Yahoo Finance
Merck's WINREVAIR Phase 2 CADENCE Trial Shows Positive Proof-of-Concept In … Nasdaq

Timeline

Last Updated Mar 29, 2026